A safer treatment path for high-risk children to overcome food allergies

by University of British ColumbiaCredit: Unsplash/CC0 Public DomainNew research from the University of British Columbia reveals a safe path to overcoming food allergies for older children and oth

Updated on: March 07,2024

A safer treatment path for high-risk children to overcome food allergies

by University of British ColumbiaCredit: Unsplash/CC0 Public DomainNew research from the University of British Columbia reveals a safe path to overcoming food allergies for older children and oth

Updated on:March 07,2024

Osteoarthritis: Carbohydrate-binding protein promotes inflammation

by Medical University of ViennaFunction and effect of galectin-1 in osteoarthritis identified for the very first timeMore and more people, particularly older people, are suffering from osteoarthr

Updated on: March 24,2024

Osteoarthritis: Carbohydrate-binding protein promotes inflammation

by Medical University of ViennaFunction and effect of galectin-1 in osteoarthritis identified for the very first timeMore and more people, particularly older people, are suffering from osteoarthr

Updated on:March 24,2024

1 billion people worldwide will suffer from arthritis by 2050

by Cara MurezThe degenerative joint disease osteoarthritis affects 15% of the global population over age 30, so by 2050 that could be nearly 1 billion people, researchers say.Living longer and obesity

Updated on: May 08,2024

1 billion people worldwide will suffer from arthritis by 2050

by Cara MurezThe degenerative joint disease osteoarthritis affects 15% of the global population over age 30, so by 2050 that could be nearly 1 billion people, researchers say.Living longer and obesity

Updated on:May 08,2024

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther

Updated on: March 19,2024

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther

Updated on:March 19,2024

Many risk factors contribute to worsening of quality of life in people with knee OA

by University of Eastern FinlandCredit: CC0 Public DomainA new study from the University of Eastern Finland shows that the health-related quality of life of most people who have had or have a hig

Updated on: April 20,2024

Many risk factors contribute to worsening of quality of life in people with knee OA

by University of Eastern FinlandCredit: CC0 Public DomainA new study from the University of Eastern Finland shows that the health-related quality of life of most people who have had or have a hig

Updated on:April 20,2024

Upadacitinib beats placebo for psoriatic arthritis

For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of theNew England J

Updated on: May 26,2024

Upadacitinib beats placebo for psoriatic arthritis

For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of theNew England J

Updated on:May 26,2024

Decline in risk of dementia and heart failure in patients with rheumatoid arthritis

by European Alliance of Associations for RheumatologyCredit: CC0 Public DomainRheumatoid arthritis (RA) is an inflammatory autoimmune disease that causes pain, swelling and stiffness in the joints. It

Updated on: May 08,2024

Decline in risk of dementia and heart failure in patients with rheumatoid arthritis

by European Alliance of Associations for RheumatologyCredit: CC0 Public DomainRheumatoid arthritis (RA) is an inflammatory autoimmune disease that causes pain, swelling and stiffness in the joints. It

Updated on:May 08,2024

Chemical stimuli can support growing of stable cartilage cells

by Umea UniversityRho-kinase inhibition cause disappearance of cellular adhesion sites. The colors of the figure shows the staining for actin stress fibers (red), adhesion plaques-related vinculi

Updated on: May 08,2024

Chemical stimuli can support growing of stable cartilage cells

by Umea UniversityRho-kinase inhibition cause disappearance of cellular adhesion sites. The colors of the figure shows the staining for actin stress fibers (red), adhesion plaques-related vinculi

Updated on:May 08,2024

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Updated on: June 01,2024

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Updated on:June 01,2024

Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy

by Universidad de NavarraStudy proposes a new therapeutic approach against cancer that dissociates efficacy and toxicity in the use of combined immunotherapy in animal models. This clinical strat

Updated on: May 08,2024

Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy

by Universidad de NavarraStudy proposes a new therapeutic approach against cancer that dissociates efficacy and toxicity in the use of combined immunotherapy in animal models. This clinical strat

Updated on:May 08,2024

CAR-T therapy modifications provide new promise for cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainNew research led by Dr. John Maher, from the School of Cancer & Pharmaceutical Sciences, working for Leucid Bio and with biotech company L

Updated on: April 09,2024

CAR-T therapy modifications provide new promise for cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainNew research led by Dr. John Maher, from the School of Cancer & Pharmaceutical Sciences, working for Leucid Bio and with biotech company L

Updated on:April 09,2024

Compound found to trigger innate immunity against viruses

by Bobbi Nodell,University of WashingtonCells under a microscope in a UW Medicine immunity lab. Credit: Dennis WiseResearch from UW Medicine and collaborators indicates that a drug-like molecule

Updated on: May 08,2024

Compound found to trigger innate immunity against viruses

by Bobbi Nodell,University of WashingtonCells under a microscope in a UW Medicine immunity lab. Credit: Dennis WiseResearch from UW Medicine and collaborators indicates that a drug-like molecule

Updated on:May 08,2024